117 related articles for article (PubMed ID: 38902747)
1. Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance.
Kim J; Shin BS; Kim DH; Shin DI; Ahn SH; Kim JG; Ryu SH; Moon HR; Kang HG; Jeong H; Yum KS; Chae HY; Kim DH; Kang K; Kim J
BMC Med Genomics; 2024 Jun; 17(1):166. PubMed ID: 38902747
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia.
Clavijo LC; Al-Asady N; Dhillon A; Matthews RV; Caro J; Tun H; Rowe V; Shavelle DM
Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):516-520. PubMed ID: 29221961
[TBL] [Abstract][Full Text] [Related]
3. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
[TBL] [Abstract][Full Text] [Related]
4. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
[TBL] [Abstract][Full Text] [Related]
5. Does the response to aspirin and clopidogrel vary over 6 months in patients with ischemic heart disease?
Khanna V; Mikael R; Thayalasamy K; Sambu N; Dimitrov BD; Englyst N; Calver AL; Corbett S; Gray H; Simpson IA; Wilkinson JR; Curzen N
J Thromb Haemost; 2015 Jun; 13(6):920-30. PubMed ID: 25809653
[TBL] [Abstract][Full Text] [Related]
6. Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting.
Kim BJ; Kwon JY; Jung JM; Lee DH; Kang DW; Kim JS; Kwon SU
J Neurosurg; 2014 Oct; 121(4):891-8. PubMed ID: 25036195
[TBL] [Abstract][Full Text] [Related]
7. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between SNPs in Candidate Genes and VerifyNow-Detected Platelet Responsiveness to Aspirin and Clopidogrel Treatment.
Cui H; Lin S; Chen X; Gao W; Li X; Zhou H; Du W; Wang S; Zhao R
Cardiovasc Drugs Ther; 2015 Apr; 29(2):137-46. PubMed ID: 25860557
[TBL] [Abstract][Full Text] [Related]
9. Aspirin platelet reactivity on platelet function and clinical outcome in minor stroke or transient ischemic attack.
Xu Y; Chen W; Jiang L; Wang Y; Zhao X; Liu L; Yao D; Guo L; Wang Y; Pan Y; Wang Y
J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106683. PubMed ID: 35914511
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease.
Yeo KK; Armstrong EJ; López JE; Chen DC; Westin GG; Li CS; Anderson D; Hua A; Singapuri A; Amsterdam EA; Chiamvimonvat N; Laird JR
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1308-1317. PubMed ID: 29411531
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
[TBL] [Abstract][Full Text] [Related]
12. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
[TBL] [Abstract][Full Text] [Related]
13. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N;
Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700
[TBL] [Abstract][Full Text] [Related]
14. On-treatment platelet reactivity through the thromboxane A
Karwatowska-Prokopczuk E; Li L; Yang J; Witztum JL; Tsimikas S
J Thromb Thrombolysis; 2023 Aug; 56(2):226-232. PubMed ID: 37338713
[TBL] [Abstract][Full Text] [Related]
15. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy.
Timur AA; Murugesan G; Zhang L; Barnard J; Bhatt DL; Kottke-Marchant K
Thromb Res; 2014 Jul; 134(1):96-104. PubMed ID: 24852729
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-18 levels as a predictor for patients with genetic dysfunction of cytochrome P450 2C19 in dual antiplatelet therapy with clopidogrel.
Ishimatsu T; Sasaki KI; Kakuma T; Harada A; Hirakawa Y; Fukumoto Y; Ueno T
J Cardiol; 2020 Nov; 76(5):479-486. PubMed ID: 32616329
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to antiplatelet agents assessed by a point-of-care platelet function test and thromboembolic adverse events in neurointervention].
Haraguchi K; Miyachi S; Izumi T; Matsubara N; Naito T; Asai T; Yamanouchi T; Wakabayashi T
No Shinkei Geka; 2012 May; 40(5):399-406. PubMed ID: 22538281
[TBL] [Abstract][Full Text] [Related]
18. Multi-institutional patterns of clopidogrel response among patients undergoing transcarotid artery revascularization.
Rokosh RS; Rockman C; Garg K; Wang SK; Motaganahalli RL; Schroeder AC; Sobraske PJ; Stoner MC; Tarbunou YA; Marmor RA; Malas MB; Maldonado TS
Vascular; 2024 Jun; 32(3):558-564. PubMed ID: 36428145
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
[TBL] [Abstract][Full Text] [Related]
20. Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.
Xu K; Ye S; Zhang S; Yang M; Zhu T; Kong D; Chen J; Xu L; Li J; Zhu H; Wang F; Yang L; Zhang J; Fan Y; Ying L; Hu X; Zhang X; Chan NC; Li C
Circ Cardiovasc Interv; 2019 May; 12(5):e007019. PubMed ID: 31018667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
